The trajectory of Viagra presents a interesting case for investors in the drug sector. While initially a tremendous success, creating huge profits, the exclusivity end and the subsequent flood of generic versions have https://knockoff527596.izrablog.com/42119137/the-little-copyright-and-big-pharma-a-risky-bet